Medis Laboratories SA, Tunisia

The MédiS Laboratories is a limited company under Tunisian law with a mandate to manufacture and market various generic medications. Founded in 1995, MédiS has obtained the operating license in June 1999. The first Market Authorization dates back to the month of February 2000. Currently, Médis has a large portfolio of proven products as well as a wide sales network. Médis produced nearly 200 quality products. Several other marketing authorizations have already been filed and are being processed.

Pharma Solution represents the following Medis products in the United Arab Emirates

Website : https://www.medis.com.tn/index.php?id=5&L=2

ANTI-INFLAMMATORY / ANTI-INFLAMMATORY STEROIDAL

MP-40 (methylprednisolone Sodium Succinate) 40mg

Powder for injection preparation

Anti-Biotics

Levodis (levofloxacin) 5mg/ml

injectable solution for infusion

Anesthesiology / local or regional anesthesia

MEDICAINE 2% AVEC ADRENALINE®

INJECTABLE SOLUTION cartridge DENTAL

Infectiology / Systemic Antifungal

FLUKAS (Fkuconazole) 2mg/ml 50ml and 100ml

Solution for Injection

Blood and Haemostasis / Anticoagulants

ENOXA (Enoxparine Sodium) 2000

INJECTABLE SOLUTION

ENOXA (Enoxparine Sodium) 4000 L

ENOXA (Enoxparine Sodium) 6000

ENOXA   (Enoxparine Sodium) 8000

Neurology - Psychatrie / Multiple Sclerosis: Interferon

GLITAXON (GLATIRAMER ACETATE) 20mg

Injectable solution PFS

Oncology / Associated Treatments

ZOLEDRA (ZOLEDRONIC ACID) 4 mg/5 ml

Powder for injection preparation